Centogene

Under a new agreement, Centogene will integrate its CentoMD database of phenotype/genotype variants of rare diseases into the Qiagen bioinformatics platform.

Centogene said it will use the funds to accelerate growth and expansion in the areas of genetic testing, pharmaceutical collaborations, and big-data solutions.

The partners will work to offer panel-based genetic characterization for a US-based cohort.

The company has installed Illumina's HiSeq X sequencing platform and expects to sequence 20,000 genomes by the end of next year.

The two companies plan to join their respective technologies in order to help clinicians better interpret genetic variant data.

The privately-held German firm also plans to offer genetic tumor profiling and noninvasive prenatal testing.

NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services today announced it has acquired the Canadian business of Centogene for an undisclosed amount.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.